Milrinone Lactate In Dextrose Injection, Solution
Product Images NDC 0143-9718

5 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Milrinone Lactate In Dextrose (NDC 0143-9718). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Milrinone Lactate In Dextrose Injection 1)

Chemical Structure (Milrinone Lactate In Dextrose Injection 1)
Chemical structure diagram of Milrinone Lactate, showing the molecular formula and structural components including a pyridine ring, cyano group, and lactone ring, accompanied by the formula representing the lactate component (CH3CHOHCOOH).*
FDA Label Image

Bag Label (Milrinone Lactate In Dextrose Injection 2)

Bag Label (Milrinone Lactate In Dextrose Injection 2)
Label for Milrinone Lactate in 5% Dextrose Injection, an intravenous injection solution with a concentration of 20 mg per 100 mL (200 mcg/mL). The label states it is a sterile, nonpyrogenic, single-dose flexible container of 100 mL. Manufactured by Hikma FarmacĂȘutica (Portugal) and distributed by West-Ward Pharmaceutical Corp, USA. Includes usage, storage instructions, and barcode with NDC 0143-9719-01.*
FDA Label Image

Label (Milrinone Lactate In Dextrose Injection 3)

Label (Milrinone Lactate In Dextrose Injection 3)
Label for Milrinone Lactate in 5% Dextrose Injection, an intravenous injection solution with strength of 20 mg/100 mL (200 mcg/mL). The label states it is a sterile, nonpyrogenic single-dose flexible container, 100 mL. The product is labeled by Hikma Pharmaceuticals USA Inc. and includes instructions for use, storage, and disposal.*
FDA Label Image

Label (Milrinone Lactate In Dextrose Injection 4)

Label (Milrinone Lactate In Dextrose Injection 4)
Milrinone Lactate in Dextrose Injection 40 mg/200 mL (200 mcg/mL) solution in a 200 mL single dose flexible container label. The intravenous injection product is sterile, nonpyrogenic, and manufactured by Hikma Pharmaceuticals USA Inc., distributed by West-Ward Pharmaceutical Corp. The label includes storage instructions and dosage caution statements.*
FDA Label Image

Label (Milrinone Lactate In Dextrose Injection 5)

Label (Milrinone Lactate In Dextrose Injection 5)
Label for Milrinone Lactate in 5% Dextrose Injection, 40 mg/200 mL (200 mcg/mL) intravenous injection solution in a 200 mL single dose flexible container. The product is sterile and nonpyrogenic, labeled for prescription use only, and manufactured by Hikma Pharmaceuticals USA Inc. Storage and usage instructions are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.